Thyroid cancer after in vitro fertilization: A retrospective, non-consecutive case-series analysis

Gynecological Endocrinology

Volumn 30, Issue 8, 2014, Pages 569-572

  Pazaitou Panayiotou, Kalliopi ^a   Toulis, Konstantinos A ^a,b   Mandanas, Stylianos ^a   Tarlatzis, Basil C ^b  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Estrogen; in vitro fertilization; Papillary thyroid cancer; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE;

ABLATION THERAPY; ADULT; ARTICLE; CASE STUDY; CLINICAL ARTICLE; COHORT ANALYSIS; DELAYED DIAGNOSIS; DISTANT METASTASIS; FEMALE; FERTILIZATION IN VITRO; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MEDICAL HISTORY; MEDICAL RECORD REVIEW; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; TUMOR VOLUME; CANCER STAGING; CARCINOMA; INFERTILITY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PREGNANCY; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; THYROID NEOPLASMS;

ADULT; CARCINOMA; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREGNANCY; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 84904430648     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.907258     Document Type: Article

References (34)

1. Ceresini G, Corcione L, Michiara M, et al. Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. Cancer 2012; 118:5473-80.
2. Londero SC, Krogdahl A, Bastholt L, et al. Papillary thyroid carcinoma in Denmark 1996-2008: an investigation of changes in incidence. Cancer Epidemiol 2013;37:e1-6.
3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
4. Reynolds RM, Weir J, Stockton DL, et al. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol 2005;62:156-62. (Pubitemid 40203909)
5. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115: 3801-7.
6. McNally RJ, Blakey K, James PW, et al. Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. European J Epidemiol 2012;27:615-22.
7. Horner MJ, Ries LAG, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. http://seercancergov/csr/1975-2006/ [last accessed 2012].
8. Horn-Ross PL, Chang ET, Clarke CA, et al. Nativity and papillary thyroid cancer incidence rates among Hispanic women in California. Cancer 2012;118:216-22.
9. Brindel P, Doyon F, Rachedi F, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol 2008;167:219-29.
10. Rossing MA, Voigt LF, Wicklund KG, et al. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 2000;151:765-72. (Pubitemid 30461140)
11. Di Vito M, De Santis E, Perrone GA, et al. Overexpression of estrogen receptor-alpha in human papillary thyroid carcinomas studied by laser- capture microdissection and molecular biology. Cancer Sci 2011;102:1921-7.
12. Kansakar E, Chang YJ, Mehrabi M, et al. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer. Am Surgeon 2009;75:785-9 (discussion 789).
13. Magri F, Capelli V, Rotondi M, et al. Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patients risk. Endocrine-related cancer 2012; 19:463-71.
14. Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586-90. (Pubitemid 29515949)
15. Brinton LA, Scoccia B, Moghissi KS, et al. Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 2004;19: 2005-13. (Pubitemid 39236465)
16. Brinton LA, Lamb EJ, Moghissi KS, et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 2004;103: 1194-203. (Pubitemid 40458949)
17. Althuis MD, Scoccia B, Lamb EJ, et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 2005;193:668-74. (Pubitemid 41261460)
18. Jensen A, Sharif H, Olsen JH, et al. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. Am J Epidemiol 2008;168:49-57. (Pubitemid 351881887)
19. Kallen B, Finnstrom O, Lindam A, et al. Malignancies among women who gave birth after in vitro fertilization. Human reproduction 2011;26:253-8.
20. Doyle P, Maconochie N, Beral V, et al. Cancer incidence following treatment for infertility at a clinic in the UK. Human reproduction 2002;17:2209-13.
21. Gauthier E, Paoletti X, Clavel-Chapelon F, et al. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Human reproduction 2004;19: 2216-21. (Pubitemid 39406678)
22. Hannibal CG, Jensen A, Sharif H, et al. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 2008;23:451-6. (Pubitemid 351651256)
23. La Vecchia C, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer causes &control: CCC 1999;10:157-66. (Pubitemid 29161107)
24. Dor J, Lerner-Geva L, Rabinovici J, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324-7. (Pubitemid 34083556)
25. McLeod DS, Watters KF, Carpenter AD, et al. Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab 2012;97:2682-92.
26. Yli-Kuha AN, Gissler M, Klemetti R, et al. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Hum Reprod 2012;27:1149-55.
27. Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor - a review. Placenta 2008;29:169-77.
28. Brinton LA, Westhoff CL, Scoccia B, et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology 2005;16:500-7. (Pubitemid 40847834)
29. Dekkers OM, Egger M, Altman DG, et al. Distinguishing case series from cohort studies. Ann Intern Med 2012;156:37-40.
30. Chen YK, Lin CL, Cheng FT, et al. Cancer risk in patients with Hashimotos thyroiditis: a nationwide cohort study. Br J Cancer 2013;109:2496-501.
31. Vaiman M, Olevson Y, Habler L, et al. The estrogen receptors in the papillary carcinoma of the thyroid gland. Oncol Res 2010;18: 537-40.
32. Davis PJ, Lin HY, Mousa SA, et al. Overlapping nongenomic and genomic actions of thyroid hormone and steroids. Steroids 2011;76: 829-33.
33. Mazzaferri EL. Approach to the pregnant patient with thyroid cancer. The J Clin Endocrinol Metab 2011;96: 265-72.
34. Negro R, Valcavi R, Toulis KA. Incidental thyroid cancer in toxic and nontoxic goiter: is TSH associated with malignany rate? Results of a meta-analysis. Endocr Pract 2013;19:212-18.